Speaker Profile
Ph.D., Founder, Travera
Biography
Dr. Reid is a serial entrepreneur focused on precision medicine. He founded Complete Genomics (GNOM: NASDAQ), a DNA sequencing company that revolutionized whole human genome sequencing (now part of MGI), and Travera, and cancer therapy selection company that is revolutionizing the way oncologists select effective drugs for their patients. Prior to Complete Genomics he founded two enterprise software companies, Eloquent (ELOQ: NASDAQ), an internet video company, and Verity (VRTY: NASDAQ), an enterprise search engine company.
Talk
Personalizing Therapies When Biomarkers Fail
Cancer therapies that cure cancer or achieve decades of remission have eluded cancer researchers and drug developers for all by a tiny fraction of cancer patients. An alternative approach to therapy selection may offer durable therapeutic response for most cancer patients.
Clinical Dx Showcase:
Travera
Travera uses a unique non-genomic technology to measure the response of live cancer cells to cancer drugs. Its 2-day CLIA-certified test enables oncologists to select effective therapies for their late-stage patients who are out of good options.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
